Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy
NCT ID: NCT02443675
Last Updated: 2015-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2015-05-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated
NCT02069067
Precise Care for Cancer Related Fatigue
NCT04843657
Early Interventional Treatment for Cancer Pain
NCT05366413
Ambulatory Cancer Pain Management: A Feasibility Study
NCT00507351
Using Mini Program for Self-management VS Conventional Pharmaceutical Care for Cancer Pain
NCT04844645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cure Cancer Worldwide, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
gary l smith, mba
Role: STUDY_DIRECTOR
Cure Cancer Worldwide, LLC
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C4 OS-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.